Qiu Wen-Ze, Peng Xing-Si, Xia Hai-Qun, Huang Pei-Yu, Guo Xiang, Cao Ka-Jia
Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, Guangzhou, 510060, People's Republic of China.
Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Guangzhou, People's Republic of China.
J Cancer Res Clin Oncol. 2017 Aug;143(8):1563-1572. doi: 10.1007/s00432-017-2401-y. Epub 2017 Mar 25.
To compare the clinical outcomes and toxicities of two-dimensional conventional radiotherapy (2D-CRT) and intensity-modulated radiotherapy (IMRT) for the treatment of children and adolescent nasopharyngeal carcinoma (NPC).
A total of 176 children with non-metastatic NPC treated at Sun Yat-sen University Cancer Center between October 2003 and September 2013 were included in this study. Of the 176 patients, 74 received 2D-CRT and 102 were treated with IMRT. The clinical outcomes and acute and late toxicities were determined and compared.
The IMRT group achieved significantly higher overall survival (OS) (90.4% vs. 76.1% at 5 year, P = 0.007) and disease-free survival (DFS) (85.7% vs. 71.2%, P = 0.029) mainly due to an improvement in locoregional relapse-free survival (LRRFS) (97.9 vs. 88.3%, P = 0.049). After stratification by disease stage, IMRT provided significant benefits for patients with stage III-IV disease in terms of OS, LRRFS and DFS. Multivariate analyses indicated that the treatment group (2D-CRT vs. IMRT) was a prognostic factor for OS, LRRFS and DFS. A significant reduction in Grade 2-4 xerostomia (52.7 vs. 34.3%, P = 0.015) and hearing loss (40.5 vs. 22.5%, P = 0.010) was observed in patients treated by IMRT.
IMRT provides better locoregional relapse-free survival and overall survival, especially in late-stage children and adolescent NPC patients, and is associated with a lower incidence of Grade 2-4 xerostomia as well as hearing loss compared with 2D-CRT. Distant metastasis remains a challenge in the treatment of children and adolescent NPC.
比较二维传统放疗(2D-CRT)与调强放疗(IMRT)治疗儿童及青少年鼻咽癌(NPC)的临床疗效和毒性反应。
本研究纳入2003年10月至2013年9月在中山大学肿瘤防治中心接受治疗的176例非转移性NPC患儿。176例患者中,74例接受2D-CRT治疗,102例接受IMRT治疗。对临床疗效以及急性和晚期毒性反应进行测定和比较。
IMRT组的总生存率(OS)(5年时为90.4%对76.1%,P = 0.007)和无病生存率(DFS)(85.7%对71.2%,P = 0.029)显著更高,主要是由于局部区域无复发生存率(LRRFS)有所改善(97.9对88.3%,P = 0.049)。按疾病分期分层后,IMRT在OS、LRRFS和DFS方面为III-IV期疾病患者带来显著益处。多因素分析表明,治疗组(2D-CRT对IMRT)是OS、LRRFS和DFS的一个预后因素。接受IMRT治疗的患者出现2-4级口干(52.7%对34.3%,P = 0.015)和听力损失(40.5%对22.5%,P = 0.010)的情况显著减少。
IMRT可提供更好的局部区域无复发生存率和总生存率,尤其是在晚期儿童及青少年NPC患者中,并且与2D-CRT相比,2-4级口干以及听力损失的发生率更低。远处转移仍是儿童及青少年NPC治疗中的一项挑战。